Clinical trials recruiting in Yiyang, China
3
Recruiting trials
6
Conditions
Phase breakdown
Phase 2 2Phase 3 1
Conditions recruiting in Yiyang, China
| Condition | Trials |
|---|---|
| COPD | 1 |
| Chronic Obstructive Pulmonary Disease | 1 |
| Lung cancer | 1 |
| Lupus | 1 |
| Non-Small Cell Lung Cancer | 1 |
| Systemic Lupus Erythematosus, SLE | 1 |
Recruiting trials in Yiyang, China
- A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
Common questions
How many clinical trials are recruiting in Yiyang, China?
3 recruiting trials have at least one study site in Yiyang, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.